ADmit Therapeutics

Promental Health

Promental Health develops a blood test using microRNA biomarkers and machine learning for the early diagnosis of Alzheimer's disease for healthcare providers.

Cytox

This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.

Pre Diagnostics

This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.

Neurotrack

Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

Altoida

This company develops an augmented reality platform to assess cognitive function and detect Alzheimer's disease for healthcare providers and clinical researchers.

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.